ANI Pharmaceuticals, Inc. (BST:BSFA)

Germany · Delayed Price · Currency is EUR

64.50

0.00 (0.00%)

At close: Mar 19, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Rare Disease and Brands	483.93M	294.34M	197.50M	81.15M	-
Rare Disease and Brands Growth	64.41%	49.03%	143.38%	-	-
Generics and Other	399.43M	320.03M	289.31M	235.24M	-
Generics and Other Growth	24.81%	10.62%	22.99%	-	-
Generics, Established Brands, and Other	-	-	-	-	216.14M
Generics, Established Brands, and Other Growth	-	-	-	-	3.67%
Total	883.37M	614.38M	486.82M	316.39M	216.14M
Total Growth	43.78%	26.20%	53.87%	46.38%	3.67%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	852.44M	604.99M	486.25M	312.43M	211.89M
United States Growth	40.90%	24.42%	55.64%	47.45%	4.44%
International	30.92M	9.39M	565.00K	3.96M	-
International Growth	229.42%	1561.42%	-85.73%	-	-
Canada	-	-	-	-	4.24M
Canada Growth	-	-	-	-	-24.15%
Total	883.37M	614.38M	486.82M	316.39M	216.14M
Total Growth	43.78%	26.20%	53.87%	46.38%	3.67%

Source: S&P Global Market Intelligence.